Reference Medicine presents findings of MammaPrint® recurrence risk stratification in early-stage breast carcinomas at SABCS 2024

Dec 11, 2024

Study investigating the correlation between high TILs and early-stage breast cancer recurrence risk using MammaPrint® and BluePrint® genomic tests.

As presented at the San Antonio Breast Cancer Symposium 2024.

• Presented by: Zoran Gatalica, MD
• Poster: P1-11-17, December 11, 2024, 10:00AM – 2:00 PM